Form 4 for ASTH Astrana Health, Inc.
Accepted 2025-03-28 00:00:00 ET · period of report 2025-03-26 · accession 0001104659-25-028974 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-03-28 | 2025-03-26 | ASTH | Sobotka Glenn | CAO | A - Grant | $0.00 | +14.7K | 6,432 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-26 | A | A | 8,269 | $0.00 | 14,701 | D | — | — | (F2) Restricted a grant of performance-based restricted stock. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares will vest subject to the achievement of applicable performance goals and applicable time-based conditions. (F3) Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 6,432 shares, which will vest in four equal annual installments beginning on March 26, 2026; and (ii) 8,269 shares, which will vest subject to the achievement of certain performance goals. |
| 2 | Common | Common Stock | 2025-03-26 | A | A | 6,432 | $0.00 | 6,432 | D | — | — | (F1) Represents a grant of restricted stock. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares will vest in four equal annual installments beginning on March 26, 2026. |